Discontinued — last reported Q4 '21
Wells Fargo & Company Short-Term Borrowings increased by 76.2% to $32.28B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 76.9%, from $139.78B to $32.28B. Over 5 years (FY 2020 to FY 2025), Short-Term Borrowings shows a downward trend with a -20.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $45.64B | $41.98B | $34.41B | $33.60B | $37.08B | $48.38B | $51.15B | $81.01B | $84.26B | $93.33B | $89.56B | $109.01B | $118.83B | $111.89B | $108.81B | $139.78B | $188.00B | $230.65B | $18.32B | $32.28B |
| QoQ Change | — | -8.0% | -18.0% | -2.3% | +10.3% | +30.5% | +5.7% | +58.4% | +4.0% | +10.8% | -4.0% | +21.7% | +9.0% | -5.8% | -2.8% | +28.5% | +34.5% | +22.7% | -92.1% | +76.2% |
| YoY Change | — | — | — | — | -18.8% | +15.3% | +48.6% | +141.1% | +127.3% | +92.9% | +75.1% | +34.6% | +41.0% | +19.9% | +21.5% | +28.2% | +58.2% | +106.1% | -83.2% | -76.9% |